Companies

FENNEC PHARMACEUTICALS INC. (FENC) SEC filings

CIK 0001211583 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in A1 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)44.6 M21.3 M1.5 M
Net income (USD)-23.7 M-17.3 M
Diluted EPS (USD/shares)-0.34-0.6-0.9

Latest filings

FiledFormDescriptionPeriod
2026-10-19SCHEDULE 13G/ASCHEDULE 13G/A
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-10-01442026-09-30
2026-10-01442026-09-30
2026-10-01442026-09-30
2026-10-01442026-09-30
2026-10-01442026-09-30
2026-09-178-K8-K items 8.01,9.012026-09-17
2026-09-16442026-09-15
2026-09-15144144
2026-09-01144144
2026-09-01442026-08-31
2026-08-31442026-08-31
2026-08-31442026-08-31
2026-08-31442026-08-31
2026-08-31442026-08-31
2026-08-31442026-08-31
2026-08-31144144
2026-08-28442026-08-27
2026-08-27144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 290, 8-K 130, 144 60, 10-Q 59, 3 35, SC 13G/A 25, DEF 14A 20, 6-K 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=FENC (0.002 USD), /gw/filings/filings?ticker=FENC&form=8-K, /gw/filings/facts?ticker=FENC&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange